To evaluate the effect of food on the Pharmacokinetics (PK) of AZD0328

Study identifier:D0190C00009

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Open, Randomized, Single-Dose, Two-Treatment (Fed versus Fasting), Two-Period Cross-Over Single-Centre Study to Evaluate the Effect of Food on the Pharmacokinetics of AZD0328 Following Oral Administration (Capsule) in Healthy Male Subjects

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD0328

Sex

Male

Actual Enrollment

14

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Sept 2008
Primary Completion Date: 01 Oct 2008
Study Completion Date: 01 Oct 2008

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Other

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria